142 related articles for article (PubMed ID: 38158418)
21. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation.
Wu J; Huang M; Wu Y; Hong Y; Cai L; He R; Luo Y; Wang P; Huang M; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8897-8912. PubMed ID: 37154929
[TBL] [Abstract][Full Text] [Related]
22. Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis.
Spiotto MT; Jefferson G; Wenig B; Markiewicz M; Weichselbaum RR; Koshy M
JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):691-699. PubMed ID: 28426848
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
24. Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection.
Nie Z; Zhao P; Shang Y; Sun B
BMC Cancer; 2021 Apr; 21(1):372. PubMed ID: 33827452
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population-based study.
He J; Ni JP; Li GB; Yao J; Ni B
Clin Respir J; 2023 Mar; 17(3):197-210. PubMed ID: 36718941
[TBL] [Abstract][Full Text] [Related]
26. Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis.
Guo M; Li B; Yu Y; Wang S; Xu Y; Sun X; Wang L; Yu J
Cancer Med; 2019 May; 8(5):2587-2598. PubMed ID: 30945441
[TBL] [Abstract][Full Text] [Related]
27. Prognostic nomogram based on immune scores for laryngeal squamous cell cancer.
Liao L; Chen W; Lai H; Yi X; Wang D
Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):141-148. PubMed ID: 32638085
[TBL] [Abstract][Full Text] [Related]
28. Comparison of treatment modalities for selected advanced laryngeal squamous cell carcinoma.
Wushouer A; Li W; Zhang M; Lei D; Pan X
Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):361-371. PubMed ID: 33864482
[TBL] [Abstract][Full Text] [Related]
29. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
[TBL] [Abstract][Full Text] [Related]
31. Clinical effect of postoperative chemoradiotherapy in resected advanced laryngeal squamous cell carcinoma.
Zhang M; Deng W; Gong H; Li C; Wang Y; Liu X; Tao L; Zhou L
Oncol Lett; 2019 May; 17(5):4717-4725. PubMed ID: 30988826
[TBL] [Abstract][Full Text] [Related]
32. Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma.
Xu C; Chen YP; Liu X; Tang LL; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Li WF; Lin AH; Sun Y; Ma J
Cancer Sci; 2017 Jun; 108(6):1253-1262. PubMed ID: 28383806
[TBL] [Abstract][Full Text] [Related]
33. Identification of optimal primary tumor resection candidates for metastatic gastric cancer: Nomograms based on propensity score matching.
Li Z; Zheng H; Zhao Z; Chen G; Wang Z; Amin B; Zhang N
Cancer Med; 2023 Jun; 12(12):13063-13075. PubMed ID: 37096953
[TBL] [Abstract][Full Text] [Related]
34. Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.
Awan MJ; Gittleman H; Barnholtz-Sloan J; Machtay M; Nguyen-Tan PF; Rosenthal DI; Schultz C; Huth BJ; Thorstad WL; Frank SJ; Kim H; Foote RL; Lango MN; Shenouda G; Suntharalingam M; Harris J; Zhang Q; Le QT; Yao M;
Oral Oncol; 2021 May; 116():105241. PubMed ID: 33640577
[TBL] [Abstract][Full Text] [Related]
35. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
36. Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer.
Sun L; Candelieri-Surette D; Anglin-Foote T; Lynch JA; Maxwell KN; D'Avella C; Singh A; Aakhus E; Cohen RB; Brody RM
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1022-1028. PubMed ID: 36136306
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
Front Public Health; 2022; 10():969030. PubMed ID: 36203704
[TBL] [Abstract][Full Text] [Related]
38. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma.
Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG
BMC Cancer; 2020 Nov; 20(1):1095. PubMed ID: 33176731
[TBL] [Abstract][Full Text] [Related]
39. [Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)].
Wang XM; Wang L; Wang X; Chen JQ; Li C; Zhang WC; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Lu N; Han C; Pang QS; Wang P; Sun XC; Zhang KX; Li GF; Li L; Liu ML; Wang YD; Qiao XY; Zhu SC; Zhou ZM; Zhao YD; Xiao ZF
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):889-896. PubMed ID: 34407597
[No Abstract] [Full Text] [Related]
40. Optimal treatment strategy and prognostic analysis for hypopharyngeal squamous-cell carcinoma patients with T3-T4 or node-positive: A population-based study.
Zheng L; Fang S; Ye L; Cai W; Xiang W; Qi Y; Wu H; Yang C; Zhang R; Liu Y; Liu Y; Wu C; Yu H
Eur J Surg Oncol; 2023 Jul; 49(7):1162-1170. PubMed ID: 36977614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
